Does TOFERSEN Cause Dyspnoea? 12 Reports in FDA Database

Q: Does TOFERSEN cause Dyspnoea?

12 reports of Dyspnoea have been filed with the FDA for TOFERSEN, representing 3.3% of all TOFERSEN adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Dyspnoea have been filed in association with TOFERSEN (QALSODY). This represents 3.3% of all adverse event reports for TOFERSEN.

Reports of Dyspnoea with TOFERSEN

3.3%

of all TOFERSEN reports

Deaths

Hospitalizations

How Dangerous Is Dyspnoea From TOFERSEN?

Of the 12 reports, 5 (41.7%) required hospitalization.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOFERSEN. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does TOFERSEN Cause?

Procedural pain (42) Amyotrophic lateral sclerosis (38) Headache (37) Post lumbar puncture syndrome (34) Death (26) Back pain (20) Fatigue (17) Fall (16) Pain in extremity (16) Pain (14)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Which TOFERSEN Alternatives Have Lower Dyspnoea Risk?

TOFERSEN vs TOLNAFTATE TOFERSEN vs TOLODODEKIN ALFA TOFERSEN vs TOLTERODINE TOFERSEN vs TOLVAPTAN TOFERSEN vs TOPAMAX

TOFERSEN Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea TOFERSEN Demographics